To the editor: Infants younger than 1 year of age with acute myeloid leukemia (AML) often exhibit high-risk clinical and cytogenetic features.[1][1][⇓][2][⇓][3]-[4][4] They are also at increased risk of pulmonary and infectious toxicities, early death (ED), and treatment-related mortality (TRM
No takes yet. Share an insight, caveat, or question.
Guest et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: